King & Wood Mallesons’ cross-border team, advised Luye Pharma Hong Kong Limited (“Luye Pharma”) on its transaction signed with AstraZeneca relating to the sale and licence of the rights to Seroquel...

09 May 2018

A major Chinese technology firm has fallen into troubled waters with the U.S. Department of Commerce due to violations of U.S. economic sanctions against certain foreign nations.

03 May 2018

Setting up the KWM International Center is a significant strategic deployment for the firm.

02 May 2018

King & Wood Mallesons (KWM) was the biggest winner with 12 awards at the Thomson Reuters ALB China Law Awards 2018 held in Beijing.

20 April 2018